DexCom, Inc.

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-17 pm EDT			5-day change	1st Jan Change
81.83 ^USD	-1.41%		-4.49%	+5.22%

Jun. 17	Dexcom Insider Sold Shares Worth $517,906, According to a Recent SEC Filing	MT
Jun. 16	DexCom, Inc., Q1 2025 Earnings Call, May 01, 2025

Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users

Published on 06/10/2025 at 10:07

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about DexCom, Inc.

Dexcom Insider Sold Shares Worth $517,906, According to a Recent SEC Filing	Jun. 17	MT
DexCom, Inc., Q1 2025 Earnings Call, May 01, 2025	Jun. 16
Truist Initiates DexCom at Buy With $102 Price Target	Jun. 16	MT
Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users	Jun. 10	RE
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing	Jun. 09	CI
Jefferies Adjusts Price Target on DexCom to $110 From $105, Maintains Buy Rating	May. 30	MT
Goldman Sachs Initiates DexCom at Buy With $104 Price Target	May. 30	MT
Citigroup Adjusts Price Target on DexCom to $102 From $82, Maintains Buy Rating	May. 22	MT
DexCom Adds President Role to COO Jake Leach	May. 13	MT
DexCom, Inc. Announces Promotion of Jake Leach to the Expanded Role of President and COO	May. 13	CI
DexCom, Inc. Appoints Renée Galá to Audit and Compensation Committees Effective May 9, 2025	May. 09	CI
Insulet beats quarterly profit estimates on insulin pump demand	May. 08	RE
Barclays Adjusts DexCom Price Target to $93 From $90, Maintains Equal Weight Rating	May. 05	MT
Analyst recommendations: Amazon, PepsiCo, Linde, Pfizer, Crowdstrike Holdings...	May. 05
Equities Advance After Jobs Data; Wall Street Notches Back-to-Back Weekly Gains	May. 02	MT
Equity Markets Close Higher as April Jobs Data Beats Expectations	May. 02	MT
US Equities Markets End Higher Friday as US Adds More Jobs Than Expected	May. 02	MT
Sector Update: Health Care Stocks Climb Late Afternoon	May. 02	MT
DexCom, Inc. Announces Resignation of Karen Dahut as Director, Effective May 8, 2025	May. 02	CI
Sector Update: Health Care	May. 02	MT
Equity Markets Rise After Nonfarm Payrolls Beat Expectations	May. 02	MT
Jobs Report Helps Boost Equities Intraday; Apple Falls	May. 02	MT
Top Midday Gainers	May. 02	MT
US Equity Indexes Jump Following Strong Jobs Report, Easing China Trade Tensions	May. 02	MT
Canaccord Genuity Adjusts Price Target on DexCom to $106 From $103	May. 02	MT

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.7% of net sales.

Employees

10,250

Sector

Medical Equipment, Supplies & Distribution

Calendar

Jul. 23 - Q2 2025 Earnings Release (Projected)

More about the company